CRISPR Therapeutics (CRSP) Q2 2026 Earnings

11MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-2.4
-1.99
-1.58
-1.16

Details

Expected EPS
-1.219583
Actual EPS
N/A
Surprise EPS
1.22
Surprise Percent
+100%

Description

CRISPR Therapeutics (CRSP) will report earnings of for Q2 2026 on May 11, 2026.

0 Comments

Share your thoughts